Enrollment Goals Exceeded Through High Touch, High Tech For A Dermatology Study Of Adolescent Patients
Source: United BioSource LLC (UBC)

UBC was selected by a large biopharmaceutical company to manage a U.S. - based Phase IV randomized, placebo controlled clinical trial of patients with severe acne. The study included 284 patients, ages 9-11 years. Continue reading to see how as a result of UBC’s innovative services, not only was the enrollment goal achieved, but it was exceeded by 60%.
VIEW THE CASE STUDY!
Log In
Signing up provides unlimited access to:
Free Sign Up

Signing up provides unlimited access to:
- Trend and Leadership Articles
- Case Studies
- Extensive Product Database
- Premium Content
HELLO. PLEASE LOG IN.
X
Not yet a member of Clinical Leader? Register today.
ACCOUNT SIGN UP
X
Please fill in your account details
ACCOUNT SIGN UP
United BioSource LLC (UBC)
This website uses cookies to ensure you get the best experience on our website. Learn more